Complications of diabetes: progress, but significant challenges ahead.
作者信息
Chowdhury Tahseen A, Shaho Shang, Moolla Ahmad
机构信息
Department of Diabetes and Metabolism, The Royal London Hospital, London, UK.
出版信息
Ann Transl Med. 2014 Dec;2(12):120. doi: 10.3978/j.issn.2305-5839.2014.08.12.
Abstract
摘要
相似文献
1
Complications of diabetes: progress, but significant challenges ahead.糖尿病并发症：取得进展，但未来仍面临重大挑战。
Ann Transl Med. 2014 Dec;2(12):120. doi: 10.3978/j.issn.2305-5839.2014.08.12.
2
Diabetes--the road ahead.糖尿病——未来之路。
Am J Med. 1988 Nov 28;85(5A):166-71. doi: 10.1016/0002-9343(88)90411-1.
3
A national progress report on diabetes: successes and challenges.一份关于糖尿病的国家进展报告：成就与挑战。
Diabetes Technol Ther. 2005 Feb;7(1):198-203. doi: 10.1089/dia.2005.7.198.
4
Publisher Correction: Therapies for rare diseases: therapeutic modalities, progress and challenges ahead.出版商更正：罕见病治疗方法：治疗方式、进展与未来挑战。
Nat Rev Drug Discov. 2020 Apr;19(4):291. doi: 10.1038/s41573-019-0059-7.
5
Pancreatic islet transplantation in the treatment of diabetes mellitus.胰岛移植治疗糖尿病
Best Pract Res Clin Endocrinol Metab. 2001 Jun;15(2):241-64. doi: 10.1053/beem.2001.0138.
6
Child health in China: great progress but challenges ahead.中国儿童健康：取得巨大进步，但仍面临挑战。
Lancet. 2016 Jan 16;387(10015):200. doi: 10.1016/S0140-6736(16)00093-3. Epub 2016 Jan 15.
7
Measles in Switzerland - progress made, but communication challenges lie ahead.瑞士的麻疹疫情——虽已取得进展，但未来仍面临沟通挑战。
Swiss Med Wkly. 2019 Jun 11;149:w20105. doi: 10.4414/smw.2019.20105. eCollection 2019 Jun 3.
8
Presidential Address: 50 Years of Progress-More Challenges Ahead.主席致辞：50年的进步——前路仍有更多挑战。
Transplantation. 2016 Dec;100(12):2493-2495. doi: 10.1097/TP.0000000000001535.
9
The FORGE AHEAD clinical readiness consultation tool: a validated tool to assess clinical readiness for chronic disease care mobilization in Canada's First Nations.“奋勇向前”临床准备情况咨询工具：一种经过验证的工具，用于评估加拿大原住民慢性病护理动员的临床准备情况。
BMC Health Serv Res. 2017 Mar 23;17(1):233. doi: 10.1186/s12913-017-2175-6.
10
Nursing, health education and health promotion: lessons learned, progress made and challenges ahead.护理、健康教育与健康促进：经验教训、取得的进展及面临的挑战
Health Educ Res. 1998 Jun;13(2):i-v. doi: 10.1093/her/13.2.163.
引用本文的文献
1
Ferroptosis as a potential therapeutic target for obesity-related metabolic diseases.铁死亡作为肥胖相关代谢性疾病的潜在治疗靶点。
Front Pharmacol. 2025 Jul 4;16:1581632. doi: 10.3389/fphar.2025.1581632. eCollection 2025.
2
MiR214-3p Ameliorates Diabetic Cardiomyopathy by Inhibiting Ferroptosis.MiR214-3p通过抑制铁死亡改善糖尿病心肌病。
Cardiovasc Toxicol. 2025 Jun;25(6):884-897. doi: 10.1007/s12012-025-09992-4. Epub 2025 Apr 7.
3
HOXD9/APOC1 axis promotes macrophage M1 polarization to exacerbate diabetic kidney disease progression through activating NF-κB signaling pathway.HOXD9/APOC1 轴通过激活 NF-κB 信号通路促进巨噬细胞 M1 极化，从而加剧糖尿病肾病的进展。
Hereditas. 2024 Nov 7;161(1):40. doi: 10.1186/s41065-024-00345-9.
4
The Mitigatory Effect of Shen-Qi Compound on the Diabetic Thoracic Aortic Complications through Inhibiting the Inflammatory Microenvironment by miR-223-3p/RBP-J/IRF8 Axis.参芪复方通过miR-223-3p/RBP-J/IRF8轴抑制炎症微环境对糖尿病胸主动脉并发症的缓解作用。
Evid Based Complement Alternat Med. 2022 Sep 28;2022:6686931. doi: 10.1155/2022/6686931. eCollection 2022.
5
Correlation Among Self-Care Ability, Psychological Status, and Quality of Life in Discharged Patients with Hepatolithiasis Complicated with Diabetes Mellitus and T-Tube.肝内胆管结石合并糖尿病及 T 管引流出院患者自我护理能力、心理状态与生活质量的相关性
Front Surg. 2022 May 16;9:907900. doi: 10.3389/fsurg.2022.907900. eCollection 2022.
6
Ferroptosis and ferritinophagy in diabetes complications.糖尿病并发症中的铁死亡和铁蛋白自噬。
Mol Metab. 2022 Jun;60:101470. doi: 10.1016/j.molmet.2022.101470. Epub 2022 Mar 15.
7
Is the Duration of Diabetes Diseases Positively Associated With Knowledge About Diabetic Complications? Knowledge of Diabetes Mellitus Complications and Associated Factors Among Type-2 Diabetic Patients in Public Hospitals of Addis Ababa, 2020.糖尿病病程与对糖尿病并发症的了解是否呈正相关？2020 年，在亚的斯亚贝巴公立医院的 2 型糖尿病患者中，糖尿病并发症知识及相关因素。
Front Public Health. 2022 Feb 21;9:812586. doi: 10.3389/fpubh.2021.812586. eCollection 2021.
8
Valsartan alleviates the blood-brain barrier dysfunction in db/db diabetic mice.缬沙坦可减轻 db/db 糖尿病小鼠的血脑屏障功能障碍。
Bioengineered. 2021 Dec;12(1):9070-9080. doi: 10.1080/21655979.2021.1981799.
9
Effect of Pharmacist-Led Intervention on Progression of Diabetic Complications at Two Tertiary Care Hospitals of Malaysia.药剂师主导的干预措施对马来西亚两家三级护理医院糖尿病并发症进展的影响。
J Pharm Bioallied Sci. 2021 Apr-Jun;13(2):193-198. doi: 10.4103/jpbs.JPBS_488_20. Epub 2021 May 26.
10
Improved Endothelium-Dependent Relaxation of Thoracic Aorta in Niclosamide-Treated Diabetic Rats.尼氯硝唑治疗糖尿病大鼠胸主动脉内皮依赖性舒张功能改善。
Cardiovasc Toxicol. 2021 Jul;21(7):563-571. doi: 10.1007/s12012-021-09647-0. Epub 2021 Mar 27.
本文引用的文献
1
Changes in diabetes-related complications in the United States, 1990-2010.美国 1990-2010 年糖尿病相关并发症的变化。
N Engl J Med. 2014 Apr 17;370(16):1514-23. doi: 10.1056/NEJMoa1310799.
2
Preventing diabetes: a call for concerted national action.预防糖尿病：呼吁全国采取一致行动。
Clin Med (Lond). 2013 Aug;13(4):328-9. doi: 10.7861/clinmedicine.13-4-328.
3
The association between diabetes and an episode of depressive symptoms in the 2002 World Health Survey: an analysis of 231,797 individuals from 47 countries.2002 年世界卫生调查中糖尿病与抑郁症状发作之间的关联：来自 47 个国家的 231797 人的分析。
Diabet Med. 2013 Jun;30(6):e208-14. doi: 10.1111/dme.12193. Epub 2013 Apr 25.
4
Primary and secondary prevention of cardiovascular disease in diabetes with aspirin.糖尿病患者心血管疾病的阿司匹林一级和二级预防
Diab Vasc Dis Res. 2012 Oct;9(4):243-4. doi: 10.1177/1479164112455534. Epub 2012 Aug 31.
5
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).2型糖尿病高血糖管理：以患者为中心的方法：美国糖尿病协会（ADA）和欧洲糖尿病研究协会（EASD）的立场声明
Diabetes Care. 2012 Jun;35(6):1364-79. doi: 10.2337/dc12-0413. Epub 2012 Apr 19.
6
The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials.基于血管紧张素转换酶抑制剂（ACE 抑制剂）的治疗方案对血管疾病患者或有血管疾病高风险患者治疗效果的一致性：ADVANCE、EUROPA 和 PROGRESS 试验个体数据的综合分析
Eur Heart J. 2009 Jun;30(11):1385-94. doi: 10.1093/eurheartj/ehp103. Epub 2009 Apr 4.
7
Glucose control and vascular complications in veterans with type 2 diabetes.2型糖尿病退伍军人的血糖控制与血管并发症
N Engl J Med. 2009 Jan 8;360(2):129-39. doi: 10.1056/NEJMoa0808431. Epub 2008 Dec 17.
8
10-year follow-up of intensive glucose control in type 2 diabetes.2型糖尿病强化血糖控制的10年随访
N Engl J Med. 2008 Oct 9;359(15):1577-89. doi: 10.1056/NEJMoa0806470. Epub 2008 Sep 10.
9
Effects of intensive glucose lowering in type 2 diabetes.强化降糖对2型糖尿病的影响。
N Engl J Med. 2008 Jun 12;358(24):2545-59. doi: 10.1056/NEJMoa0802743. Epub 2008 Jun 6.
10
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.2型糖尿病患者强化血糖控制与血管转归
N Engl J Med. 2008 Jun 12;358(24):2560-72. doi: 10.1056/NEJMoa0802987. Epub 2008 Jun 6.
Zotero 插件